G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/30/2002	CN1376910A Quantum resonator for testing male or female eggs
10/30/2002	CN1376779A Process for separating cells and its application
10/30/2002	CN1376715A Polypeptide-human acanthotic microtubule bindin-93.36 and polynucleotide for coding it
10/30/2002	CN1376713A Polypeptide-olfactory receptor protein -9.25 and polynucleotide for coding it
10/30/2002	CN1376706A Polypeptide-human macro protein -28.71 and polynucleotide for coding it
10/30/2002	CN1376704A Polypeptide-human macro protein -24.97 and polynucelotide for coding it
10/30/2002	CN1376701A Polypeptide-human nucleic 20.24 and polynucleotide for coding it
10/30/2002	CN1376698A Polypeptide-human zinc finger protein -57.21 and polynucleotide for coding it
10/30/2002	CN1376697A Polypeptide-human zinc finger protein 47.17 and polynucleotide for coding it
10/30/2002	CN1376689A Polypeptide-human myelin development regulation protein-21.78 and polynucleotide for coding it
10/30/2002	CN1376682A Polypeptide-human member protein-47.96 and polynucleotide for coding it
10/30/2002	CN1093637C High resistance lining layer crack test analyser
10/30/2002	CA2383662A1 Methods and products for identifying modulators of p2x7 receptor activity, and their use in the treatment of skeletal disorders
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6473632 Total hemoglobin concentration measurement
10/29/2002	US6473512 Apparatus and method for a custom soft-solid hearing aid
10/29/2002	US6473190 Optical volume sensor
10/29/2002	US6473175 Method for analyzing impurities in a gas stream
10/29/2002	US6473173 Method for determining the content of predetermined ingredients with stochastic distribution in goods which are of a solid and nonhomogeneous consistency
10/29/2002	US6473169 Integrated leak and vision inspection system
10/29/2002	US6472520 Rat PEG-3 promoter
10/29/2002	US6472516 Progestin-regulated gene
10/29/2002	US6472508 Human tumor suppressor
10/29/2002	US6472504 Inhibitors of collagen assembly
10/29/2002	US6472486 Nitroxide control agents having an alpha carbon atom bearing a destabilizing substituent such as hydrogen
10/29/2002	US6472436 Blocking amyloid protein toxicity in cells using polycylic compounds. also provided are novel methods of decreasing amyloid protein production in cells and methods of inhibiting cell death. invention methods can be used to prevent and treat
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472377 Use of YNES, essential bacterial genes and polypeptides
10/29/2002	US6472365 Pharmaceuticals and assays using enzyme subunits
10/29/2002	US6472228 Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
10/29/2002	US6472227 A fluorescein moiety is included in the tracer, while a poly(amino acid) forms a part of the immunogen for determining the amount of barbiturate in fluids, especially biological fluids such as serum, plasma or urine
10/29/2002	US6472226 Test strip or dipstick for measuring spermatozoa with a nitrocellulose zone which captures sperm bound to label, but not free labeling compound allowing visual identification of sperm presence
10/29/2002	US6472224 Biosensor with modified precious metal surface and process for the preparation thereof
10/29/2002	US6472223 Adding an iodide solution and chloramine-t to sample; producing iodine in sufficient concentration to react with any residual disinfectant removing agent in the sample; determining the quantity of unreacted iodine in the sample
10/29/2002	US6472222 Method of estimating rate of nicotine metabolism in individuals
10/29/2002	US6472221 Lifetime-based sensing of sodium and potassium
10/29/2002	US6472215 Analyzes blood cell distribution patterns obtained from two separate blood measurement results, determines the presence of nucleated red blood cells, and further enumerates nucleated red blood cells in a blood sample
10/29/2002	US6472206 In situ growth, freezing and testing of cultured cells
10/29/2002	US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472168 Process for counting sperms and reagent therefor
10/29/2002	US6472167 Measure viable bacteria as a function of the activities of bacterial enzymes, phosphatases, glucosidases, and aminopeptidases; presence detected by a fluorescent signal
10/29/2002	US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002	US6472161 Method of evaluating blood clot lysis condition
10/29/2002	US6472160 Apparatus for accurate analysis of viable body fluids
10/29/2002	US6472152 Transformed salmonellas that are bioluminescent and the signal can be assayed as light production when induced by stresses
10/29/2002	US6472148 Molecular recognition at surfaces derivatized with self-assembled monolayers
10/29/2002	US6472146 Methods for identification on internalizing ligands and identification of known and putative ligands
10/29/2002	US6472144 High throughput screening method and apparatus
10/29/2002	US6472143 Determining the amount of the complex in a sample and correlating the amount to the presence or absence of a tumor
10/29/2002	US6472142 Providing a cell with apoptin which interferes with bip/grp78-mediated apoptosis inhibiting activity; antitumor therapy
10/29/2002	US6472141 Kinase assays using polycations
10/29/2002	US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002	US6471993 Microstructure having voids located within said semi-solid network; tissue engineering scaffolds
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	US6471962 Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
10/29/2002	US6471960 Methods for the prevention or treatment of alzheimer's disease
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	US6471819 Method and device for coating a surface with a plastic film
10/29/2002	US6471660 Non-invasively obtaining mammary fluid; determining a risk of a mammary gland disease such as cancer; quantifing the amount of a biological factor, especially a carotenoid, in the mammary fluid and comparing to a control
10/29/2002	US6471136 Biosensors for monitoring air conditioning and refrigeration processes
10/29/2002	US6471069 Device for separating components of a fluid sample
10/29/2002	US6470978 Fluid drilling system with drill string and retro jets
10/29/2002	US6470760 Method and apparatus for automatically analyzing trace substance
10/29/2002	US6470730 Dry transfer method for the preparation of explosives test samples
10/29/2002	EP1144092A4 Integrated portable biological detection system
10/29/2002	CA2215922C Methods for screening compounds for estrogenic activity
10/29/2002	CA2212747C Mhc-antigen complexes for detecting and purifying antigen-specific t cells
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2115671C Sol-gel encapsulated enzyme
10/29/2002	CA2068662C Method and apparatus for measuring a parameter of a gas in isolation from gas pressure fluctuations
10/29/2002	CA2063431C Receptors for fibroblast growth factors
10/29/2002	CA2045552C Cancer related haptoglobin
10/27/2002	CA2383392A1 Bio-device, and quantitative measurement apparatus and method using the same
10/25/2002	WO2001078652A2 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	CA2443806A1 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	CA2344971A1 Regulation of jnk activity by modulation of the interaction between the endocytic protein endophilin and the germinal center kinase-like kinase
10/24/2002	WO2002084301A2 Screening assay for agents modulating activity of the abca1 protein
10/24/2002	WO2002084300A2 Diagnosing sjogren's syndrome
10/24/2002	WO2002084299A2 Method and apparatus for detecting response to damage in plants
10/24/2002	WO2002084298A2 Medicaments which are modulators of hm74 and/or hm74a activity
10/24/2002	WO2002084297A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
10/24/2002	WO2002084296A2 Method for selecting immunological binding molecules
10/24/2002	WO2002084295A2 Method for assaying flowing media for microbial toxins
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002084293A2 Multiple analyte assaying device with a multiple sample introduction system
10/24/2002	WO2002084292A1 Inverse emulsion methods of making polymeric imprint beads
10/24/2002	WO2002084291A1 Specimen analyzing implement
10/24/2002	WO2002084290A1 Method of quantifying antigen expression
10/24/2002	WO2002084289A1 Methods for measuring lymphocyte activation by mitogens and antigens
10/24/2002	WO2002084288A2 Individualization of therapy with antiarrhythmics
10/24/2002	WO2002084287A1 Cardiovascular disease and thrombotic risk diagnostic tests
10/24/2002	WO2002084286A1 Screening method
10/24/2002	WO2002084285A2 Gradient resolved hybridisation platform
10/24/2002	WO2002084283A2 Method for determining analyte molecules in a sample
10/24/2002	WO2002084282A1 Method for determining the feeding with fresh grass of an animal
10/24/2002	WO2002084281A1 Encapsulated cell indicator system
10/24/2002	WO2002084280A1 Insect ammunition vectors and methods of use to identify pesticide targets
10/24/2002	WO2002084278A1 Indicator for calcium and magnesium

1 ... 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 ... 3937